Global overview of injecting drug use and HIV infection

dc.creatorMcCoy, Clyde B.
dc.creatorRodríguez, Frank
dc.date.accessioned2015-05-27T21:58:46Z
dc.date.accessioned2019-04-25T15:43:38Z
dc.date.available2015-05-27T21:58:46Z
dc.date.available2019-04-25T15:43:38Z
dc.date.created2015-05-27T21:58:46Z
dc.date.issued2005-03-19
dc.identifierhttp://www.thelancet.com/journals/lancet/issue/vol365no9464/PIIS0140-6736(05)X7929-6
dc.identifier0140-6736
dc.identifierhttp://hdl.handle.net/10669/13490
dc.identifier10.1016/S0140-6736(05)71117-X
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/2387370
dc.description.abstractLate in 2004, Carmen Aceijas and colleagues, on behalf of the United Nations Reference Group on HIV/AIDS Prevention and Care among IDU in Developing and Transitional Countries, presented global estimates of the prevalence of injecting drug use and the prevalence of HIV in such users.1 These authors did a Herculean task in searching for and compiling these important estimates. Not surprisingly, data are sparse or missing for many transitional and developing countries, particularly those in Africa and the Caribbean.
dc.languageen_US
dc.publisherlancet 265 p. 1008-1009
dc.sourceThe Lancet Journal 365(9464): 1008-1009
dc.subjectHIV/AIDS
dc.subjectVIH/SIDA
dc.subjectSalud pública
dc.titleGlobal overview of injecting drug use and HIV infection
dc.typeArtículos de revistas
dc.typeContribución a publicación periódica


Este ítem pertenece a la siguiente institución